Expand CLDI Menu
CLDI MENU

CLDI Latest Press Releases

-- September 17, 2026 --

Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering Globe Newswire 9:10 AM

-- September 8, 2026 --

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 13, 2026 --

Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:30 PM

-- July 27, 2026 --

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference Globe Newswire 8:00 AM

-- July 21, 2026 --

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers Globe Newswire 8:00 AM

-- July 20, 2026 --

Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026 Globe Newswire 4:30 PM

-- July 8, 2026 --

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 Globe Newswire 4:05 PM

-- June 24, 2026 --

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit Globe Newswire 8:00 AM

-- June 23, 2026 --

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors Globe Newswire 8:00 AM

-- June 16, 2026 --

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study Globe Newswire 8:00 AM

-- June 8, 2026 --

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026 Globe Newswire 8:00 AM

-- May 26, 2026 --

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting Globe Newswire 8:00 AM

-- May 22, 2026 --

Calidi Biotherapeutics Provides Required NYSE American Disclosure Globe Newswire 6:00 PM

-- May 14, 2026 --

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights Globe Newswire 4:10 PM

-- May 13, 2026 --

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston Globe Newswire 8:00 AM

-- April 29, 2026 --

Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI Globe Newswire 8:00 AM

-- April 21, 2026 --

Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 Globe Newswire 8:00 AM

-- April 20, 2026 --

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes